Scinai Immunotherapeutics (SCNI) Total Debt (2018 - 2025)

Scinai Immunotherapeutics has disclosed Total Debt across 8 years of filings, most recently posting $816000.0 for Q4 2025.

• Total Debt for Q4 2025 came in at $816000.0, up 19.3% year-over-year; the trailing twelve-month figure through Dec 2025 was $816000.0 (up 19.3% YoY), and the FY2025 annual result was $816000.0, up 19.3% from the prior year.
• Total Debt came in at $816000.0 for Q4 2025 at Scinai Immunotherapeutics, up from $790000.0 in the prior quarter.
• In the past five years, Total Debt ranged from a high of $70.3 billion in Q2 2021 to a low of $644000.0 in Q3 2024.
• The 5-year median for Total Debt is $20.0 million (2024), against an average of $7.7 billion.
• Across the five-year window, Total Debt tumbled 99.98% in 2022 and jumped 44.21% in 2023, its largest moves.
• Scinai Immunotherapeutics' Total Debt stood at $27.5 million in 2021, then retreated by 25.69% to $20.5 million in 2022, then retreated by 3.42% to $19.8 million in 2023, then sank by 96.54% to $684000.0 in 2024, then grew by 19.3% to $816000.0 in 2025.
• The last three Total Debt figures came in at $816000.0 (Q4 2025), $790000.0 (Q2 2025), and $684000.0 (Q4 2024), per Business Quant data.